Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates
JAC-Antimicrobial Resistance · 07.01.2026 · 8 (1)
DOI: 10.1093/jacamr/dlaf252 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 21.01.2026. Verfasst von Camila Solar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FONDECYT, Beca Doctorado Nacional, ANID.
Abstract (Originalsprache)
Background
Metallo-β-lactamase (MBL)-producing carbapenemase-resistant Enterobacterales infections are associated with significant mortality. Several β-lactam/β-lactamase inhibitor combinations (BL/BLI) with promising activity against MBLs are in the pipeline.
Objective
To investigate the in vitro activity of upcoming BL/BLI agents against Enterobacter hormaechei clinical isolates co-producing NDM and VIM enzymes.
Methods
Eleven E. hormaechei isolates co-harbouring blaNDM-7 and blaVIM-1 were identified from 10 patients admitted to a tertiary hospital in Santiago, Chile, between July 2022 and July 2023. Reference broth microdilution (BMD) panels were developed to determine minimum inhibitory concentrations (MICs) to aztreonam/avibactam, cefepime/taniborbactam, cefepime/zidebactam, cefiderocol and cefiderocol/xeruborbactam. Cefiderocol population analysis profile–area under the curve (PAP–AUC) was performed in strains exhibiting cefiderocol susceptibility to assess for cefiderocol heteroresistance. Long-read sequencing, using the Oxford Nanopore Technologies platform, was conducted on all isolates to characterize the genomic background of blaNDM-7 and blaVIM-1.
Results
Among the 11 E. hormaechei isolates assemblies revealed blaNDM-7 and blaVIM-1 were located on separate plasmids. All isolates were susceptible to aztreonam/avibactam, cefepime/taniborbactam and cefepime/zidebactam. Cefiderocol susceptibility was variable; the addition of xeruborbactam restored susceptibility.
Conclusions
Our findings indicate that E. hormaechei clinical isolates co-producing NDM and VIM metallo-carbapenemases exhibited susceptibility to all tested novel BL/BLIs, including aztreonam/avibactam, cefepime/taniborbactam and cefepime/zidebactam. The combination of cefiderocol and xeruborbactam restored the activity of cefiderocol.
Autor:innen und Institutionen
- Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
- Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile.
- Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
- Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Departamento de Laboratorios Clínicos, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
ORCID-Profile: Yehudit Bergman, Patricia García, Pranita D Tamma, Jose M Munita
Förderung
- FONDECYT
- Beca Doctorado Nacional
- ANID
Zitieren
APA
Solar, C., Diaz, L., Soto, K., Martínez, J. R. W., Canales, N., Bergman, Y., Peters, A., Araos, R., García, P., Tamma, P. D., & Munita, J. M. (2026). Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. JAC-Antimicrobial Resistance, 8(1). https://doi.org/10.1093/jacamr/dlaf252
Vancouver
Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, et al. Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. JAC-Antimicrobial Resistance. 2026;8(1). doi:10.1093/jacamr/dlaf252
BibTeX
@article{Solar2026,
author = {Solar, Camila and Diaz, Lorena and Soto, Katherine and Martínez, Jose R W and Canales, Nicolas and Bergman, Yehudit and Peters, Anne and Araos, Rafael and García, Patricia and Tamma, Pranita D and Munita, Jose M},
title = {Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/jacamr/dlaf252}
}
EUVIMED